Coastal Infusion Administers Nucala

Nucala (mepolizumab) is used to treat severe eosinophilic asthma, a type of asthma characterized by elevated levels of a type of white blood cell called eosinophils. These cells contribute to inflammation in the airways, which can lead to asthma symptoms such as wheezing, coughing, and shortness of breath.

The active substance in Nucala, mepolizumab, is a monoclonal antibody designed to attach to receptors called interleukin-5 receptors on the surface of eosinophils. By attaching to interleukin-5 and blocking its activity, Nucala reduces the number of eosinophils in the blood and lungs, reducing inflammation and resulting in a reduction in asthma attacks and improvement of symptoms.

What It Treats

Nucala is used to threat severe, eosinophilic asthma.

Prescribed By

Nucala is most often prescribed by Pulmonologists, Allergists, and Immunologists.

How it’s Administered

Nucala is administered by subcutaneous injection. Nucala injections take only a few minutes.

Frequency

Nucala is generally administered once every four weeks.

Related Drugs

Cinqair, Dupixent, Fasenra, Tezspire, Xolair

Additional Resources

• Nucala Website
• Prescribing Information
• Co-Pay Assistance

The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies